• Cy3-UTP for Fluorescent RNA Workflows

  2026-08-25

  Cy3-UTP enables direct fluorescent RNA labeling during in vitro transcription, supporting RNA imaging, binding assays, and sensitive detection workflows. This guide combines practical optimization steps with a careful comparison to CRISPR-based live-cell chromatin imaging.

• Standardized Whole-Blood Stimulation in Immunometabolism

  2026-08-25

  Zhao and colleagues present a standardized whole-blood stimulation protocol that combines innate immune challenges with targeted metabolic interventions and cytokine measurement. The workflow preserves the physiological complexity of blood while enabling cohort-scale analysis of how metabolic pathways selectively shape immune responses.

• TBK1, Microglial Pyroptosis, and Diabetic Neuropathy

  2026-08-24

  Liao et al. identify TANK-binding kinase 1 (TBK1) as a mechanistic driver of painful diabetic neuropathy by linking its activation in spinal microglia to NF-κB signaling, NLRP3 inflammasome activity, and pyroptosis. Their combination of genetic knockdown, pharmacological inhibition, behavioral testing, and tissue profiling provides a framework for studying neuroinflammation as a therapeutic axis in diabetic pain.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-08-24

  Breen and colleagues developed a genetically drug-sensitized Saccharomyces cerevisiae platform that detects TOR inhibitors at substantially lower concentrations than a wild-type yeast background. The system identified concentration-dependent activity for established inhibitors and aminophylline, while finding no evidence of TOR inhibition for several tested compounds, including nebivolol, illustrating both the platform’s screening value and its assay-specific limitations.

• CFDA-SE for Cell Proliferation Tracking

  2026-08-23

  CFDA-SE, also called Carboxyfluorescein diacetate succinimidyl ester, is a cell-permeable fluorescent labeling reagent that converts intracellular esterase activity into a durable signal. Its generation-dependent fluorescence loss supports flow-cytometric analysis of lymphocyte, fibroblast, natural killer cell, and bacterial proliferation.

• AM 281 in CB1 Neuropharmacology Workflows

  2026-08-22

  AM 281 provides a high-affinity way to interrogate CB1 signaling, from receptor assays to astrocyte GLT-1 and cognitive dysfunction models. This workflow-focused guide connects compound handling, time-resolved TBI experiments, behavioral readouts, and troubleshooting for more interpretable neuropharmacology data.

• Smoothened Function in Honeybee Olfaction

  2026-08-22

  Guo et al. characterize Smoothened (Smo) in Apis mellifera and connect antenna-enriched expression with olfactory receptor transcription, electroantennographic responses, and odor-guided behavior. The study provides integrated evidence that Hedgehog pathway activity may contribute to insect olfactory regulation, while also highlighting the need for species- and tissue-specific validation of pharmacological Smo perturbation.

• Levofloxacin in Resistance and Cell Assays

  2026-08-21

  Levofloxacin is a synthetic fluoroquinolone antibiotic with value beyond routine antibacterial testing. This article connects DNA gyrase inhibition with resistance-transmission studies and carefully controlled osteoblast and chondrocyte assays.

• Phytol, RXR Signaling, and Translational Assay Design

  2026-08-20

  Phytol offers translational researchers a distinctive combination of retinoid X receptor activity, metabolic context, and GABAergic effects. This article presents a mechanistic framework for validating Phytol and trans-Phytol, managing formulation and isomer-related variables, and designing more informative assays without overstating preclinical evidence.

• Mouse Tissue Lysis Kit (K1038): Direct PCR Guide

  2026-08-20

  The Mouse Tissue Lysis Kit (K1038) prepares mouse tissue lysates for direct PCR-based genotyping without a separate DNA extraction or purification step. It is intended for molecular biology research and genetic mutation detection workflows, not for diagnostic or medical use.

• TNF-alpha Recombinant Murine Protein: Assay Design

  2026-08-19

  Discover how TNF-alpha recombinant murine protein can be used to separate TNF receptor signaling from transcription-linked cell death. This guide integrates product specifications with the 2025 Cell study of Pol II degradation-dependent apoptosis to improve assay interpretation.

• VX-702: From Kinase Blockade to Assay Design

  2026-08-19

  VX-702 is a selective p38α MAPK inhibitor for connecting kinase activity with cytokine, phosphorylation-state, and disease-model readouts. This article explains how recent dephosphorylation research can sharpen assay design without overclaiming the compound’s mechanism.

• Patient-Derived Gastric Cancer Assembloids

  2026-08-18

  This study introduces patient-derived gastric cancer assembloids that combine tumor organoids with matched stromal subpopulations, providing a more physiologically relevant model of tumor heterogeneity and microenvironmental signaling. The system revealed stromal regulation of gene expression and drug sensitivity, supporting its use for resistance studies and individualized therapeutic testing.

• Tofacitinib Citrate: Applied JAK-STAT Workflows

  2026-08-18

  Tofacitinib citrate enables controlled studies of JAK-STAT signaling, lymphocyte proliferation, and Th1, Th2, and Th17 differentiation. Its value extends beyond immune assays: carefully tiered dosing can reveal why cytokine suppression does not always predict endothelial protection in inflammatory disorder research.

• Carvedilol Phosphate for Reproducible Cell Assays

  2026-08-17

  Learn how Carvedilol Phosphate, SKU C6404, can support better-controlled viability, proliferation, and GPCR-signaling experiments. This scenario-driven guide covers solvent selection, assay controls, ischemia–reperfusion interpretation, and practical supplier evaluation.

8042 records 1/537 page Next 12345 下5页 Last page